Results 261 to 270 of about 91,755 (270)
Some of the next articles are maybe not open access.

Nivolumab

Reactions Weekly, 2022
openaire   +1 more source

Subcutaneous Versus Intravenous Nivolumab for Renal Cell Carcinoma☆

Annals of Oncology
José M Mota   +2 more
exaly  

Nivolumab

Reactions Weekly, 2016
openaire   +1 more source

Final, 10-Year Outcomes With Nivolumab Plus Ipilimumab in Advanced Melanoma

New England Journal of Medicine
Georgina V. Long   +2 more
exaly  

Home - About - Disclaimer - Privacy